Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective

Highly Accessed Review

Does route of administration affect the outcome of TNF antagonist therapy?

Sergio Schwartzman* and G James Morgan

Arthritis Res Ther 2004, 6(Suppl 2):S19-S23  doi:10.1186/ar996

Accesses  

  • Last 30 days: 136 accesses
  • Last 365 days: 1427 accesses
  • All time: 12127 accesses

Cited by

BioMed Central: 1 citation